Asthma
Vascular endothelial growth factor governs activity in the bronchial passages of asthmatic patients
Published in Immunotherapy Weekly, January 4th, 2006
"There is increasing in vitro evidence to support a role for VEGF, a major regulator of angiogenesis, as a mediator of fibrosis associated with neovascularization. We tested the hypothesis that VEGF is involved both in increased airway mucosal vascularity and in the subepithelial fibrosis of asthmatic patients," researchers in Italy report.
"Bronchial biopsies were performed in 24 asthmatic patients and eight healthy controls. Immunostaining, using computerized image analysis, was performed using monoclonal antibodies against VEGF+ cells, type...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Immunotherapy Weekly
Source: Immunotherapy Weekly (2006-01-04)
More Articles from Immunotherapy Weekly
- Allergy & Immunology
Anti-CD23 agents such as Lumiliximab hold promise as a potential therapy for allergic diseases - Immunology
Langerhans cells reported to inhibit immune responses in the skin - Immunology
TRAF3 protein may be a key to early immune response to viruses - Rheumatology
Vascular related molecules signal active rheumatoid arthritis - Adenovirus Vector
Oncolytic adenovirus replicates selectively in tumors - Adverse Drug Reaction
Papillomavirus-associated squamous cell carcinoma developed in dog after chronic cyclosporine - More from this issue of Immunotherapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
